Novavax Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	413.8	1,123	682.16	983.71	1,982	1,146
Revenue Growth	-61.64%	64.69%	-30.65%	-50.37%	72.89%	141.02%
Cost of Revenue	88.54	73.04	202.74	343.77	902.64	-
Gross Profit	325.26	1,050	479.42	639.94	1,079	1,146
Selling, General & Admin	121.22	157.48	337.19	468.95	488.69	298.36
Research & Development	340.32	342.32	391.17	737.5	1,235	2,535
Other Operating Expenses	-	97.85	-	-	-	-
Total Operating Expenses	461.53	597.64	728.35	1,206	1,724	2,833
Operating Income	-234.12	452.8	-248.93	-566.51	-644.74	-1,687
Interest Expense	-21.9	-22.55	-20.08	-14.42	-19.88	-21.13
Other Non-Operating Income (Expense)	39.42	11.92	92.39	37.9	10.97	-6.83
Total Non-Operating Income (Expense)	17.52	-10.63	72.32	23.48	-8.91	-27.96
Pretax Income	-245.32	442.17	-176.62	-543.03	-653.65	-1,715
Provision for Income Taxes	-1.32	-1.87	-10.88	-2.03	-4.29	-29.22
Net Income	-247.73	440.3	-187.5	-545.06	-657.94	-1,744
Net Income to Common	-247.73	440.3	-187.5	-545.06	-657.94	-1,744
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	163	162	152	101	78	74
Shares Outstanding (Diluted)	164	173	152	101	78	74
Shares Change	-2.93%	13.74%	51.03%	28.89%	5.08%	29.27%
EPS (Basic)	-1.52	2.72	-1.23	-5.41	-8.42	-23.44
EPS (Diluted)	-1.52	2.58	-1.23	-5.41	-8.42	-23.44
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-38.76	-250.2	-100.32	-767.74	-504.99	268.45
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.24	-1.45	-0.66	-7.62	-6.46	3.61
Gross Margin	78.60%	93.50%	70.28%	65.05%	54.46%	100.00%
Operating Margin	-56.58%	40.30%	-36.49%	-57.59%	-32.53%	-147.13%
Profit Margin	-59.87%	39.19%	-27.49%	-55.41%	-33.20%	-152.12%
FCF Margin	-9.37%	-22.27%	-14.71%	-78.05%	-25.48%	23.42%
EBITDA	-216.3	480.41	-200.44	-525.29	-615.68	-1,674
EBITDA Margin	-52.27%	42.76%	-29.38%	-53.40%	-31.07%	-146.03%
EBIT	-234.12	452.8	-248.93	-566.51	-644.74	-1,687
EBIT Margin	-56.58%	40.30%	-36.49%	-57.59%	-32.53%	-147.13%
Effective Tax Rate	0.54%	-0.42%	6.16%	0.37%	0.66%	1.70%

SEC Filings: 10-K · 10-Q